(3R,5R)-7-(3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid, calcium salt (2:1)trihydrate (1), a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, was demonstrated to be effective in reducing both triglyceride and cholesterol. In present communication, two novel impurities i.e.,2-acetyl-4-(4-fluorophenyl)-4-oxo-N,3-diphenylbutanamide (18) and 2-(2-(3-fluoro phenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxo-N-phenylpentanamide (19)of 2-(2-(4-fluorophenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxo-N-phenylpentanamide (2),were reported along with their identification and isolation. The compounds were characterized by spectral techniques such as IR, 1HNMR, 13C NMR and mass.
Introduction
(3R,5R)-7-(3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl)-3,5-dihydroxy heptanoic acid, calcium salt (2:1)trihydrate (1) is a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor,which has been demonstrated to be effective in reducing both triglyceride and cholesterol 1 . Almost all manufacturers of this drug use 2-(2-(4-fluorophenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxo-Nphenylpentanamide (2) as a key intermediate 2, 3 ( Figure 1 ). Even negligible quantity of impurities [2] [3] [4] [5] [6] [7] may have impact on the quality of bulk drug process. Thus, high standard principles and good manufacturing practices are required for reducing impurity level. Presence of impurity, even in small quantity, may influence the efficiency and safety of the pharmaceutical products. In this present communication, we report identification, isolation and synthesis of some novel impurities, which are formed during the manufacturing of 2-(2-(4-fluorophenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxo-N-phenylpentanamide. They were characterized by spectroscopic techniques.
Experimental

General
All chemical reagents and solvents were procured from Acros, Fisher scientific Acros and Sigma-Aldrich etc., which are used without further purification. All the reactions were conducted under inert conditions. The products were purified appying column chromatography, crystalization and precipitation techniques. Silicagel (100-200 mesh) was used as a solid phase for column chromatography. Precoated silica aluminium sheets were used for TLC. The products were identified on TLC plate by using iodine or UV cabinet. NMR spectra were recorded on Bruker 400MHz by using CDCl3 and DMSO-d6 as solvents. Mass analyses were recorded on Apex. IR (KBr disc) spectra were obtained on Bruker. o C for 1 h. Then the temperature was gradually raised to 120-125°C and stirred for 6 -8 h, during which the liberated methanol was collected through distillation. The absence of starting material was monitored by TLC, using hexane/EtOAc mixtureas a mobile phase (8:2). After completion of the reaction, it was cooled cool to room temperature. The reaction mixture was quenched with 2N HCl solution (20 mL) and extracted with CH2Cl2 (30 mL). The organic layer was sequentially wash with 1N HCl (5 mL), 5% NaHCO3 (5 mL) and 5% NaCl (5 mL .2mmol), K2CO3 (8g, 57.8 mmol) and 3-oxo-Nphenylbutanamide (22) (9.5g, 46.3 mmol) was refluxed in acetone (40 mL) for 8 -10 h. The absence of starting material was monitored by TLC using hexane/EtOAc mixture as a mobile phase (8:2). Cool to 25-35°C. The mixture was cooled to room temperature, filtered and washed with acetone (20 mL). The solvent of the filtrate was removed under reduced pressure to obtain a crude solid product, to which isopropyl alcohol was added and the mixture was refluxed for 1 h. Then, the mixture was cooled to room temperature and the solid product was separated by filtration and washed with isopropyl alcohol (10 mL). It was dried at 70-80°C to obtain a white solid material which required no further purification (11.5g, 68.4% yield).m.p.174-176°C. 1 , and the mixture was stirred at room temperature for 8-10h. Absence of starting material was monitored by TLC, using a mixture of hexane/EtOAcas a mobile phase (8:2). EtOAc (20 mL) was added to the reaction mixture, stirred for 15 min, filtered and washed, with EtOAc (20 mL).The filtrate was washed sequentially with 5% NaHCO3 (2×20 mL) and 5% Na2SO3 (3×20 mL).The organic layer was concentrated under reduced pressure to give a yellow crude product. It was purified by column chromatography using silica gel (100-200 mesh) as a stationary phase, and the mixture of hexane/EtOAc as a mobile phase to obtain pure 1-(3-fluorophenyl)-2-phenylethanol (27)(5.5g). It was dissolved in 25 mL of acetone and slowly added to Jones reagent (Preparation: to 2.5g of CrO3 was added 2.5 mL of H2SO4to observe a clear solution. It was slowly added into DM water 7.5 mL) at room temperature. Absence of starting material was monitored by TLC using a mixture of hexane/EtOAc as a mobile phase (8:2).The mixture was slowly added into DM water (55 mL) and extracted with CH2Cl2 (55 mL). The organic layer was concentrated under reduced pressure to give a crude product, which was dissolved in n-hexane (50 mL) and sequentially washed with 5% NaHCO3 (2×20 mL), 5% NaHSO3 (3×20 mL) and DM water (20 mL). The organic layer was concentrated under reduced pressure to give a yellow semi solid (3.7g, 42.9% yield). 1 3.7g, 17 .27 mmol) and CH2Cl2 (37 mL) was added 0.12 mL of 30% HBr in AcOH and then a cold solution of Br2 (3.7g, 23.12 mmol) in 7.5 mL of CH2Cl2. The reaction progress was monitored by TLC using a mixture of hexane/CH2Cl2 as a mobile phase (1:1). After completion of the reaction, the organic layer was sequentially washed with 5% Na2SO3 (3×10 mL), 5% NaHCO3 (10 mL) and 5% NaCl (10 mL). It was concentrated under reduced pressure to give a brown semi solid (5g, 98.8% yield 
Synthesis of 2-(2-(3-fluorophenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxo-N-phenyl pentanamide (19):
To the mixture of K2CO3 (3.5g, 25.34 mmol) and 4-methyl-3-oxo-N-phenylpentanamide (16) (4.4g, 21.32 mmol) in acetone (15 mL) was added 2-bromo-1-(3-fluorophenyl)-2-phenylethanone (29) (5g, 17.05 mmol) in 5.5 mL of acetone. The mixture was stirred at room temperature for 6 -8 h. Absence of the starting material was monitored by TLC using hexane/EtOAc as a mobile phase (8:2). After completion of the reaction, it was filtered and washed with acetone (10 mL).The filtrate was concentrated under reduced pressure. To the remaining residue was added 20 mL isopropyl alcohol and the solution was refluxed for 1h, after which the product was collected by filtration and wash with isopropyl alcohol (5 mL). The material was dried at 70-80°C to obtain a white solid. (4g, 56% yield) 
Results and Discussion
Conclusion
To summarize, we have identified and synthesized novel impurities i.e., 2-acetyl-4-(4-fluorophenyl)-4-oxo-N,3-diphenylbutanamide (18) and 2-(2-(3-fluorophenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxo-Nphenylpentanamide (19), which form during manufacturing of 2-(2-(4-fluorophenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxo-N-phenylpentanamide (2) . Those impurities are well characterized by spectroscopic techniques. We will further study the impact of these impurities on Atorvastatin calcium (1) .
